Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Blood drug"'
Autor:
Gianni Bisogno, Roberto Calabrese, Lucia Dora Notarangelo, Giovanna Russo, Margherita Nardi, Sofia Maria Rosaria Matarese, Bruno Nobili, Domenico De Mattia, Marco Zecca, Elisa Rivetti, Paola Giordano, Emilia Parodi, Ugo Ramenghi, Giovanni Amendola, Piero Farruggia, Chiara Vimercati
We report the long-term follow-up (median 39.5 months) of 49 paediatric patients (33 females and 16 males) with refractory symptomatic immune thrombocytopenic purpura (ITP) treated with rituximab. The overall response rate was 69% (34/49 patients). T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f3dbe3a3bc94a4f8a4e604fe1e47c60
http://hdl.handle.net/2318/56906
http://hdl.handle.net/2318/56906
Autor:
Tim Ramsay, G. Le Gal, Michael J. Kovacs, Karine Lacut, Marc Carrier, David A. Anderson, Arnaud Perrier, Linda M. Vickars, Isabelle Chagnon, Susan Solymoss, M. T. Betancourt, Susan R. Kahn, P. S. Wells, Marc A. Rodger, Richard H. White, Mark Crowther
Publikováno v:
Thrombosis Research
Thrombosis Research, Elsevier, 2010, 126 (3), pp.222-6. ⟨10.1016/j.thromres.2010.06.007⟩
Thrombosis Research, Vol. 126, No 3 (2010) pp. 222-226
Thrombosis Research, Elsevier, 2010, 126 (3), pp.222-6. ⟨10.1016/j.thromres.2010.06.007⟩
Thrombosis Research, Vol. 126, No 3 (2010) pp. 222-226
International audience; INTRODUCTION: Case-control studies suggest that elevated lipoprotein (a) (Lp(a)) is a risk factor for first venous thromboembolism (VTE). Lp(a) has not been prospectively investigated as a possible risk factor for recurrent VT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::634d9beeb7c21a37b299b2c7ba0255e1
https://hal.univ-brest.fr/hal-00722005
https://hal.univ-brest.fr/hal-00722005
Autor:
Siddhartha Ganguly, Joseph P. McGuirk, Omar S. Aljitawi, J.D. Pipkin, Sunil Abhyankar, Anna Ludlow, Tara L. Lin
Publikováno v:
Blood. 120:4551-4551
Abstract 4551 Background: In a recent phase IIa open-label, randomized, cross-over design study, we evaluated the pharmacokinetics of Propylene Glycol-Free Melphalan (PG-free Mel) HCL and Alkeran in multiple myeloma patients undergoing transplantatio
Autor:
G. Fioritoni, Quaglietta Am, Antonio de Laurenzi, Pierluigi Benedetti Panici, Indovina A, Torlontano G, Luca Pierelli, Antonio Iacone, A. Montuoro, Giacomo Menichella, Domenico D'Antonio, Antonio Nicolucci, Ignazio Majolino, Luca De Rosa, Rosanna Scimè, Giuseppe Leone
Publikováno v:
British journal of haematology. 86(1)
A retrospective study was undertaken to evaluate the efficacy of autologous blood stem cell transplantation (ABSCT) in terms of haemopoietic reconstitution after ablative chemotherapy or chemo-radiotherapy. 55 patients with malignancies, observed in